2018 annual financial data
4D Molecular Therapeutics 2018 Operating margin
Direct answer
Operating margin was -73.6%.
Operating income was -10,399,000 USD and net income was -9,551,000 USD.
Operating cash flow was -16,252,000 USD.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,130,000 USD
- Operating income
- -10,399,000 USD
- Net income
- -9,551,000 USD
- Operating cash flow
- -16,252,000 USD